TRIM21 and Schwartz-Jampel syndrome: In a cohort study of 527 patients with primary SjS in China, the researchers found that the detection rate of anti-TRIM21 positivity in patients with concomitant ILD was 36% and that anti-TRIM21 was independently associated with ILD, Table 1 (95).